STAT3 and melanoma: Immune-competent C57BL/6 mice were intravenously challenged with the mouse B16 melanoma cells, followed by i.v. injection of PS-unacet.-STAT3, PS-STAT3-K685R, and PO- or PS-acet.-STAT3 peptides, as well as vehicle.